Expression of the cyclin-dependent kinase inhibitor p27 in transitional cell bladder cancers: Is it a good predictor for tumor behavior?

被引:8
作者
Latife Doganay
Semsi Altaner
Selcuk Bilgi
Esat Kaya
Galip Ekuklu
Kemal Kutlu
机构
[1] Department of Pathology, Trakya University Medical Faculty
[2] Department of Urology, Trakya University Medical Faculty
[3] Department of Public Health, Trakya University Medical Faculty
关键词
Bladder; p27; p53; PCNA; Progression; Recurrence; Transitional cell carcinoma;
D O I
10.1023/B:UROL.0000020301.39181.03
中图分类号
学科分类号
摘要
Objectives: Progression of the cell cycle is regulated by the interactions of cyclins, cyclin dependent kinases (CDKs) and CDK inhibitors (CDKIs). p27 is a member of the universal cyclin-dependent kinase inhibitor family. The level of p27 protein expression decreases during tumor development and progression in some epithelial, lymphoid and endocrine tissues. It has been suggested that p27 is an independent prognostic factor in various human cancers. The prognostic value of p27 protein expression is not completely understood in bladder cancer yet. Aims: To investigate the immunohistochemical expression of p27 in transitional cell bladder cancers and its relationship with clinicopathological data, proliferating cell nuclear antigen (PCNA) and p53 oncoprotein immunoreactivity. Methods: The expression of p27 protein was immunohistochemically analyzed in paraffin-embedded specimens of 75 patients with transitional cell carcinoma of the bladder. p27 expression was compared with tumor grade, stage, growth pattern, disease-free survival, progression, PCNA and p53 immunoreactivity. Results: Expression of p27 was not significantly related to clinicopathologic parameters, disease-free survival, progression, PCNA and p53 immunoreactivity. Conclusion: The results indicate that p27 is not a good predictor for outcome of transitional cell carcinoma of the bladder. © 2004 Kluwer Academic Publishers.
引用
收藏
页码:181 / 188
页数:7
相关论文
共 40 条
  • [1] Cotran R.S., Kumar V.K., Collins T., Pathologic Basis of Disease, pp. 95-96, (1999)
  • [2] Sgambato A., Zhang Y.-J., Arber N., Et al., Deregulated expression of p27<sup>kip1</sup> in human breast cancers, Clin. Can. Res., 3, pp. 1879-1887, (1997)
  • [3] Xiong Y., Connolly T., Futcher B., Et al., Human D-type cyclin, Cell, 65, pp. 691-699, (1991)
  • [4] Hall P.A., Levision D.A., Review: Assessment of of cell proliferation in histological material, J. Clin. Pathol., 43, pp. 184-192, (1990)
  • [5] Xiong Y., Zhang H., Beach D., D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA, Cell, 71, pp. 505-514, (1992)
  • [6] Liu Y., Marraccino R.L., Keng P.C., Requirement for proliferating cell nuclear antigen expression during stages of the Chinese hamster ovary cell cycle, Biochemistry, 28, pp. 2967-2974, (1989)
  • [7] Finlay C.A., Hinds P.W., Levine A.J., The p53 proto-oncogene can act as a suppressor of transformation, Cell, 57, pp. 1083-1093, (1989)
  • [8] Lipponen P.K., Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value, Int. J. Cancer, 53, pp. 365-370, (1993)
  • [9] Esrig D., Spruck III C.H., Nichols P.W., Et al., p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer, AJP, 143, pp. 1389-1397, (1993)
  • [10] Mostofi F., Histological Typing of Urinary Bladder Tumors, (1973)